Intracoronary infusion of mononuclear cells after PCI-treated myocardial infarction and arrhythmogenesis: is it safe?

To reduce long-term morbidity after revascularised acute myocardial infarction, different therapeutic strategies have been investigated. Cell therapy with mononuclear cells from bone marrow (BMMC) or peripheral blood (PBMC) has been proposed to attenuate the adverse processes of remodelling and subs...

Descripción completa

Detalles Bibliográficos
Autores principales: Robbers, L. F. H. J., Nijveldt, R., Beek, A. M., Kemme, M. J. B., Delewi, R., Hirsch, A., van der Laan, A. M., van der Vleuten, P. A., Piek, J. J., Zijlstra, F., van Rossum, A. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2012
Materias:
ICIN
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286504/
https://www.ncbi.nlm.nih.gov/pubmed/22351557
http://dx.doi.org/10.1007/s12471-012-0251-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286504/
https://www.ncbi.nlm.nih.gov/pubmed/22351557
http://dx.doi.org/10.1007/s12471-012-0251-4

Ejemplares similares